Britton R S, Bacon B R
Department of Internal Medicine, St. Louis University Health Sciences Center, Missouri.
Hepatogastroenterology. 1994 Aug;41(4):343-8.
An increased production of free radicals in the liver has been implicated in a variety of liver diseases. Free radicals can damage cellular macromolecules and, therefore, may participate in hepatocellular injury when produced in excess. Strong evidence exists for hepatic free radical production in animal models of iron and copper overload, ethanol consumption, and ischemia-reperfusion. Although less is known about the situation in humans with liver diseases, the available evidence is consistent with the findings in animal experiments. Treatments that reduce free radical production and/or levels have protective effects in hepatic ischemia-reperfusion. Free radical-initiated lipid peroxidation may play a role in hepatic fibrogenesis, perhaps through an effect of aldehydic peroxidation products on Kupffer cells and lipocytes. This hypothesis is supported by the observation that dietary supplementation with vitamin E has a protective effect on carbon tetrachloride-induced hepatic fibrosis. While cellular damage in human liver diseases is probably multifactorial, free radicals may play important roles in initiating and/or perpetuating this damage.
肝脏中自由基产生增加与多种肝脏疾病有关。自由基会损伤细胞大分子,因此,当自由基产生过量时可能参与肝细胞损伤。在铁和铜过载、乙醇摄入以及缺血再灌注的动物模型中,有充分证据表明肝脏会产生自由基。虽然对于患有肝脏疾病的人类情况了解较少,但现有证据与动物实验结果一致。减少自由基产生和/或水平的治疗方法对肝脏缺血再灌注具有保护作用。自由基引发的脂质过氧化可能在肝纤维化形成中起作用,也许是通过醛类过氧化产物对库普弗细胞和脂肪细胞的影响。这一假说得到以下观察结果的支持:饮食中补充维生素E对四氯化碳诱导的肝纤维化具有保护作用。虽然人类肝脏疾病中的细胞损伤可能是多因素的,但自由基可能在引发和/或持续这种损伤中起重要作用。